Prevalence of obesity, hypertension, diabetes, and metabolic syndrome and its cardiovascular complications

Current Hypertension Reviews

Volumn 6, Issue 2, 2010, Pages 73-82

  Tuck, Michael L ^a,b   Corry, Dalila B ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

Cardiovascular complications; Hypertension; Metabolic syndrome; Obesity; Type 2 diabetes

Indexed keywords

ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LUNG CANCER; METABOLIC SYNDROME X; MOLECULAR MECHANICS; MORTALITY; NATIONAL HEALTH ORGANIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SMOKING; SOCIAL STATUS; TEACHER;

EID: 77952498213     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340210791171010     Document Type: Article

References (57)

1. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med 2000; 160: 898-904.
2. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293: 1861-7.
3. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults. 1999-2000. JAMA 2002; 288: 1723-7.
4. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents. 1999-2000. JAMA 2002; 288: 1728-32.
5. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults. 1999-2002. JAMA 2004; 291: 2847-50.
6. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009; 119: 1728-35.
7. Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008; 10: 156-64.
8. Ramsey F, Ussery-Hall A, Garcia D, et al: Centers for Disease Control and Prevention (CDC). MMWR Surveill Summ 2008; 57: 1-20.
9. Masuo K, Mikami H, Ogihara T, Tuck ML. Weight gain-induced blood pressure elevation. Hypertension 2000; 35: 1135-40.
10. Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML. Beta2-and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005; 111: 3429-34.
11. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiolo 1997; 146: 214-22.
12. Resnick HE, Valsania P, Halter JB, Lin X. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Commun Health 2000; 54: 596; 602.
13. Masuo K, Mikami H, Ogohata T, Tuck ML. Weight reduction and pharmacological treatment in obese hypertensives. Am J Hypertens 2001; 14: 530-38.
14. Straznicky NE, Lambert GW, McGrane MT, et al. Weight loss may reserve blunted sympathetic neural responsiveness to glucose ingestion in obese subjectrs with metabolic syndrome. Diabetes 2009; 58: 1126-342.
15. Will JC, Williamson DF, Ford ES, Calle EE, Thun MJ. Intentional weight loss and 13-year diavetes incidence in overweight adults. Am J Public Healthy 2002; 92: 1245-8.
16. Heidmann C, Boeing H, Pischon T, Nothlings U, Joost HG, Schulze MB. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol 2009; 24: 281-8.
17. Liberopoulos EN, Mikhailidis DP, Elisaf MS. Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 2005; 6: 283-96.
18. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-9.
19. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.
20. Ogden CL, Fryar CD, Carroll MD, Flegal KM. Advance Data from Vital and Health Statics. CDC. 2004; 347: 1-20.
21. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population. Diabetes Care 2006; 29: 1263-8.
22. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007; 298: 2028-37.
23. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplam JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999; 282: 1519-22.
24. Mokdad AH, Bowman BA, Ford ES, Venicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200.
25. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000; 23: 1278-83.
26. Lopez Suarez A, Elvira Gonzalez J, Beltran Robles M, et al. Prevalence of obesity, diabetes, hypertension, hypercholesterolemia and mwetabolic syndrome in over 50-year-olds in sanlucar de Barrameda, Spain. Rev esp Cardiol 2008; 61: 1150-58.
27. Cardenas Quintana H, Sanchez Abanto J, Roldan Albieto L, Mendoza Tasayco F. Prevalence of metabolic syndrome in people 20 years old and more. Peru, 2005. Rev Esp Salud Publica 2009; 83: 257-65.
28. Centers for Disease Control and Prevention (CDC). Obesity prevalence among low-income, preschool-aged children-United States, 1998-2008. MMWR Morb Mortal Wkly Rep 2009; 58: 769-73.
29. Lee DS, Chiu M, Manuel DG, et al. for the Canadian Cardiovascular Outcomes Research Team. Trends in risk factors for cardiovasculatr disease in Canada: temporal, socio-demographic and geographic factors. CMAJ 2009; 191: E55-E66.
30. Pan W-H, Flegal KM, Chang H-Y, Yeh W-T, Yeh C-J, Lee W-C. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 2004; 79: 31-39.
31. Dhaliwal SS, Welborn TA. Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: A public health perspective. Prev Med 2009 Aug 4. [Epub ahead of print].
32. Yoshida D, Toyomura K, Fukumoto J, et al. Waist circumference and cardiovascular risk factors in Japanese men and women. J Atheroscler Throm. 2009; Aug 11. [Epub ahead of print].
33. Rider OJ, Francis JM, Ali MK, et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 2009; 54: 718-26.
34. Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med 2009; 122(12): 1106-14.
35. Redon J, Cifkova R, Laaurent S, et al. Scientific Council of the European Society of Hypertension. J Hypertens 2008; 26: 1891-900.
36. Redon J, Cifkova R, Narkiewicz K. Hypertension in the metabolic syndrome: summary of the new position statement of the European Society of Hypertension. Pol Arch Med Wewn 2009; 119: 255-60.
37. Lotufo PA, Gaziano M, Chae CU, et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 2001; 161: 242-7.
38. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among parients with type 2 diabetes mellitus: a meta -analysis. Arch Intern Med 2002; 162: 1737-45.
39. Young LH, Wackers FJ, Chyun DA, et al. for DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009; 301: 1547-55.
40. Wang SL, Head J, Steven L, Fuller JH. Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The World health organization multinational study of vascular disease in diabetes. Diabetes Care 1996; 19: 305-12.
41. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 2001; 44(Suppl 2): S14-S21.
42. Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 2002; 25: 859-64.
43. Cho E, RimmEB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002; 40: 954-60.
44. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005; 36: 1212-7.
45. Kawamoto R, Tomita H, Ohtsuka N, Inoue A, Kamitani A. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J Atheroscler Thromb 2007; 14: 78-85.
46. Bertoni A, Wong ND, Shea S, et al. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis. The Multi-Ethnic Study of Atheroclerosis (MESA). Diabetes Care 2007; 30: 2951-6.
47. Held C, Gerstein HC, Yusuf S, et al. for the ONTARGET/TRANSCEND investigators. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 2007; 115: 1371-5.
48. Schulze MB, Hoffmann K, Boeing H, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007; 30: 510-515.
49. Ting SM, Nair H, Ching I, Taheri S, Dasgupta I. Overweight, obesity and chronic kidney disease. Nephron Clin Pract 2009; 112: c121-c127.
50. Hall JE, Henegar JR, Dwyer TM, et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 2004; 11: 41-54.
51. de Carmo JM, Tallam LS, Roberts JV, et al. Imopact of obesity on renal structure and function in the presence and absence of hypertension: Evidence from melanocortin-4 receptor deficient mice. Am J Physiol Regul Integr Comp Physiol 2009; 297(3): R8031-12.
52. Shara NM, Resnick HE, Lu L, et al. Deceased GFR estimated by MDRD or Cockroft-Gault equation predicts incident CVD: the strong heart study J Nephrol 2009; 22: 373-80.
53. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
54. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-3.
55. Balkau B, Charles MA, Drivsholm T, et al. European Group for the study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European Cohorts, and an alternative definition of an insulin resistance syndrome. Diabet Metab 2002; 28: 364-76.
56. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-21.
57. Grundy SM, Brewer HB, Cleeman JI, Smith SC Jr, Lenfant C. The American Heart association, the National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.